Månsson Anne, Cardell Lars-Olaf
Laboratory of Clinical and Experimental Allergy Research, Department of Otorhinolaryngology, Malmö University Hospital, Lund University, Malmö, Sweden.
J Leukoc Biol. 2009 Apr;85(4):719-27. doi: 10.1189/jlb.0808494. Epub 2009 Jan 7.
Viral respiratory infections are increasingly implicated in allergic exacerbations. The mechanisms behind this are not known, but a virus-induced activation of eosinophils through TLRs could be involved. Herein, we investigated the expression and function of TLR7 and TLR9 in purified eosinophils from peripheral blood and assessed their role in allergic airway inflammation. Eosinophils expressed TLR7 and TLR9 proteins. Stimulation with the cognate ligands R-837 and CpG was found to prolong survival, up-regulate expression of CD11b and conversely down-regulate L-selectin expression, increase expression of the activation marker CD69, facilitate the chemotactic migration, and enhance IL-8 secretion by eosinophils. Also, CpG induced release of eosinophil-derived neurotoxin (EDN), and R-837 failed to do so. Analogously, eosinophils activated by CpG, but not R-837, promoted airway epithelial cell death and cytokine release. Priming with the allergic mediators histamine, IL-4, and most prominently IL-5, augmented the TLR-induced IL-8 and EDN secretion, revealing an ability to sensitize eosinophils for TLR7 and TLR9 activation. Moreover, the TLR responses of eosinophils were higher in allergic as compared with healthy subjects, manifested by an increase in IL-8 and EDN release. Correspondingly, allergic subjects displayed an elevated serum level of IL-5, suggesting increased IL-5-mediated priming. This study shows that activation via TLR7 and TLR9 affects several eosinophil functions and that the atopic status of the donor and the presence of a Th2-like cytokine milieu affect the outcome of the response. Thus, eosinophil activation via TLR7 and TLR9 might engender a link between viral infection and allergic exacerbations.
病毒性呼吸道感染与过敏性加重的关联日益增加。其背后的机制尚不清楚,但可能涉及病毒通过Toll样受体(TLRs)诱导嗜酸性粒细胞活化。在此,我们研究了外周血纯化嗜酸性粒细胞中TLR7和TLR9的表达及功能,并评估了它们在过敏性气道炎症中的作用。嗜酸性粒细胞表达TLR7和TLR9蛋白。发现用同源配体R-837和CpG刺激可延长嗜酸性粒细胞存活时间,上调CD11b表达,反之下调L-选择素表达,增加活化标志物CD69表达,促进趋化迁移,并增强嗜酸性粒细胞的IL-8分泌。此外,CpG诱导嗜酸性粒细胞衍生神经毒素(EDN)释放,而R-837则不能。类似地,CpG而非R-837激活的嗜酸性粒细胞可促进气道上皮细胞死亡和细胞因子释放。用过敏介质组胺、IL-4,尤其是IL-5预处理可增强TLR诱导的IL-8和EDN分泌,表明嗜酸性粒细胞对TLR7和TLR9活化具有致敏能力。此外,与健康受试者相比,过敏性受试者嗜酸性粒细胞的TLR反应更高,表现为IL-8和EDN释放增加。相应地,过敏性受试者血清IL-5水平升高,提示IL-5介导的预处理增加。本研究表明,通过TLR7和TLR9激活可影响嗜酸性粒细胞的多种功能,供体的特应性状态和Th2样细胞因子环境会影响反应结果。因此,通过TLR7和TLR9激活嗜酸性粒细胞可能在病毒感染和过敏性加重之间建立联系。